Sintx Technologies (NASDAQ:SINT – Get Free Report) and electroCore (NASDAQ:ECOR – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, earnings, analyst recommendations and dividends.
Insider and Institutional Ownership
18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 26.7% of electroCore shares are held by institutional investors. 4.1% of Sintx Technologies shares are held by insiders. Comparatively, 7.8% of electroCore shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Earnings and Valuation
This table compares Sintx Technologies and electroCore”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Sintx Technologies | $1.08 million | 7.44 | -$10.36 million | ($4.91) | -0.38 |
| electroCore | $36.97 million | 2.77 | -$13.97 million | ($1.66) | -6.84 |
Sintx Technologies has higher earnings, but lower revenue than electroCore. electroCore is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Sintx Technologies and electroCore’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Sintx Technologies | -848.20% | -354.44% | -115.37% |
| electroCore | -39.96% | -1,956.38% | -81.35% |
Analyst Recommendations
This is a summary of recent ratings and price targets for Sintx Technologies and electroCore, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Sintx Technologies | 1 | 0 | 3 | 0 | 2.50 |
| electroCore | 1 | 1 | 1 | 0 | 2.00 |
Sintx Technologies presently has a consensus price target of $9.33, indicating a potential upside of 399.11%. electroCore has a consensus price target of $18.00, indicating a potential upside of 58.59%. Given Sintx Technologies’ stronger consensus rating and higher possible upside, analysts plainly believe Sintx Technologies is more favorable than electroCore.
Summary
Sintx Technologies beats electroCore on 7 of the 13 factors compared between the two stocks.
About Sintx Technologies
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
About electroCore
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
